V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20067530 | 20133884 | 1.65 | 72 | Palliative (P) | 2016-07-03 | 2016-09-14 | Bevacizumab + Irinotecan + MdG | 02 | null | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100004687 |
| 20067942 | 20133886 | null | null | Palliative (P) | 2021-05-27 | 2021-06-04 | ECarboX | 02 | null | CETUXIMAB + FLUOROURACIL | 101215072 |
| 20067991 | 20133887 | 1.4 | 133.2 | Palliative (P) | 2016-05-20 | 2016-05-22 | POMALIDOMIDE | 02 | Y | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100025544 |
| 20068071 | 20133888 | 1.52 | 66 | Curative (C) | 2017-09-07 | 2019-10-08 | CHOP R - 21 days | 02 | N | CISPLATIN + TRASTUZUMAB | 101572306 |
| 20068083 | 20133889 | 0 | 62.4 | null | 2019-08-08 | 2019-10-11 | HEP SIOPEL 6 Cisplatin | 02 | null | RADIUM 223 | 100227267 |
| 20068143 | 20133890 | 1.54 | 96 | Palliative (P) | 2020-09-07 | 2020-09-21 | AVELUMAB + AXITINIB | 01 | null | ABEMACICLIB + FULVESTRANT | 101311949 |
| 20068190 | 20133891 | 1.71 | 9 | Palliative (P) | 2021-06-06 | 2021-06-14 | Trastuzumab + VINORELBINE | 02 | N | TEYSUNO | 100553853 |
| 20068282 | 20133892 | 1.81 | 99.6 | 03 | 2019-02-13 | 2019-03-07 | CAV | N | N | CYCLOPHOSPHAMIDE + OBINUTUZUMAB + VINCRISTINE | 101332822 |
| 20068475 | 20133893 | 1.63 | 57 | Palliative (P) | 2016-08-13 | 2017-05-19 | Cisplatin + Fluorouracil + Streptozocin | 02 | N | VINORELBINE | 101315951 |
| 20068492 | 20133894 | 1.7 | 65 | Palliative (P) | 2019-06-17 | 2019-07-01 | Topotecan (intravenous) | 02 | N | FCARBOST | 100033086 |
| 20068545 | 20133895 | 1.71 | 80 | Palliative (P) | 2017-05-04 | 2018-01-16 | Cisplatin + Fluorouracil + RT 5day | 02 | N | ECARBOX | 101533586 |
| 20068561 | 20133896 | 1.57 | 73 | null | 2020-01-10 | 2020-02-07 | Bevacizumab + FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | SCOPE2 TRIAL | 100226390 |
| 20068775 | 20133897 | 1.61 | 63.6 | Palliative (P) | 2017-08-21 | 2018-03-12 | Gemcitabine + Oxaliplatin | 02 | N | ATEZOLIZUMAB | 101559525 |
| 20069008 | 20133898 | 1.78 | 47.6 | Palliative (P) | 2017-10-25 | 2019-03-14 | Bevacizumab + Irinotecan + MdG | 02 | N | GEMCITABINE + OXALIPLATIN | 101602400 |
| 20069099 | 20133899 | 1.71 | 63.75 | null | 2019-01-17 | 2019-01-25 | PHITT C Carboplatin/Doxorubicin | N | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101047299 |
| 20069155 | 20133900 | 1.79 | 50 | Palliative (P) | 2018-11-17 | 2019-01-11 | Fluorouracil + Folinic + RT Bossett | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101117936 |
| 20069198 | 20133901 | 1.58 | 58 | 03 | 2018-11-06 | 2019-01-08 | CHOP R - 21 days | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100278818 |
| 20069324 | 20133902 | 1.58 | 45 | Palliative (P) | 2019-05-16 | 2019-05-21 | Alectinib | 02 | N | IPILIMUMAB + NIVOLUMAB | 100851664 |
| 20069403 | 20133903 | 1.77 | 72.7 | Palliative (P) | 2019-03-13 | 2019-06-07 | Melphalan IV High dose | 02 | N | CARBOPLATIN + PEMETREXED | 101010795 |
| 20069479 | 20133904 | 1.54 | 14.9 | null | 2020-01-16 | 2020-01-25 | Capecitabine+Cisplatin+Streptozocin | 02 | Y | CARBOPLATIN + TEYSUNO | 100071270 |
| 20069583 | 20133905 | 1.54 | 64.3 | Palliative (P) | 2019-08-05 | 2019-08-07 | Bortezomib + Daratumumab | 02 | N | LOMUSTINE | 100113393 |
| 20069608 | 20133906 | 1.55 | 71 | null | 2021-08-11 | 2021-09-02 | IPILIMUMAB + NIVOLUMAB | 02 | null | CETUXIMAB + IRINOTECAN | 100153357 |
| 20069745 | 20133907 | 1.84 | 69 | Adjuvant (A) | 2017-08-23 | 2017-10-01 | ECF | 02 | N | RITUXIMAB | 100677385 |
| 20069791 | 20133908 | 1.72 | 73.7 | Palliative (P) | 2021-03-13 | 2021-04-07 | CAV | 02 | N | GEMCITABINE + RT | 100948501 |
| 20070046 | 20133909 | 1.8 | 0 | Palliative (P) | 2018-10-30 | 2018-12-30 | Doxorubicin 20mg/m2 7 day | N | null | NAB-PACLITAXEL | 101510317 |
| 20070144 | 20133910 | 1.58 | 50.8 | Palliative (P) | 2019-11-11 | 2019-11-18 | Hydroxycarbamide | 02 | N | CARBOPLATIN + VINORELBINE | 100276516 |
| 20070190 | 20133911 | 1.73 | 89.1 | Palliative (P) | 2018-01-22 | 2020-02-08 | CHOP R - 21 days | N | N | CEMIPLIMAB | 100869083 |
| 20070259 | 20133912 | 1.8 | null | Palliative (P) | 2016-08-16 | 2016-08-30 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | CARBOPLATIN + PEMETREXED | 101470311 |
| 20070301 | 20133913 | 1.65 | 0 | null | 2019-04-19 | 2019-04-26 | Gemcitabine 300mg/m2 + RT | 02 | N | OLARATUMAB | 100523326 |
| 20070345 | 20133914 | 1.58 | 57.5 | Palliative (P) | 2018-06-26 | 2018-06-27 | CAM-PLEX Trial | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101842813 |
| 20070382 | 20133916 | 1.93 | 70.7 | 03 | 2017-06-20 | 2017-06-20 | IBRUTINIB | N | null | HYDROXYCARBAMIDE | 100340739 |
| 20070406 | 20133917 | 0 | 64.8 | Disease modification (D) | null | 2019-06-14 | ETOPOSIDE | N | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101067145 |
| 20070445 | 20133918 | 0 | 57.1 | Curative (C) | null | 2020-02-15 | TEMOZOLOMIDE | Y | null | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101305613 |
| 20070446 | 20133919 | 1.71 | 79.3 | Adjuvant (A) | 2021-04-27 | 2021-04-30 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | ARISTOTLE TRIAL | 100303847 |
| 20070652 | 20133920 | 1.65 | 61.4 | Palliative (P) | 2020-02-01 | 2020-02-01 | ECF | 02 | N | TOPOTECAN | 101336423 |
| 20070752 | 20133921 | 1.82 | 52.1 | null | 2017-03-24 | 2019-11-26 | DARATUMUMAB | 02 | null | MITOMYCIN | 101258011 |
| 20071309 | 20133922 | 1.75 | 57 | Palliative (P) | 2018-04-14 | 2018-04-14 | CHOP R - 21 days | 01 | N | LETROZOLE + PALBOCICLIB | 100555555 |
| 20071680 | 20133923 | 1.47 | 103.6 | Disease modification (D) | null | 2019-05-16 | Gemcitabine + Oxaliplatin | 02 | N | DOXORUBICIN | 100069084 |
| 20073014 | 20133924 | 1.65 | 50.8 | Palliative (P) | 2018-12-03 | 2018-12-17 | SCOPE 2 TRIAL | 02 | N | ACTICCA-1 TRIAL | 100024561 |
| 20073374 | 20133925 | 1.67 | 58.9 | null | 2013-05-09 | 2020-04-02 | Cisplatin + Pemetrexed | 02 | N | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 101601864 |
| 20073763 | 20133926 | 1.81 | 72.2 | Neo-adjuvant (N) | null | 2022-04-03 | CETUXIMAB + IRINOTECAN | 02 | N | LOMUSTINE | 100780633 |
| 20074557 | 20133927 | 1.79 | 85.3 | Palliative (P) | null | 2019-10-04 | FCR Oral - Cycle 2 onwards | null | null | TRABECTEDIN | 101688850 |
| 20074761 | 20133928 | 1.65 | 83.3 | null | 2015-08-21 | 2016-05-24 | Cape +Cetuximab +Oxalip (3 wk)Maint | 02 | null | IRINOTECAN + PANITUMUMAB | 101565676 |
| 20075366 | 20133929 | 1.72 | 62.3 | Curative (C) | null | 2021-01-15 | Irinotecan + Temozolomide | 01 | N | PACLITAXEL + TRASTUZUMAB | 100783629 |
| 20075782 | 20133930 | 1.82 | 82 | Neo-adjuvant (N) | null | 2019-06-19 | Topotecan (oral) | N | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100751135 |
| 20076999 | 20133931 | 1.57 | 62.8 | Palliative (P) | 2020-03-30 | 2020-03-30 | CISPLATIN + FLUOROURACIL + RT | 02 | N | NAB-PACLITAXEL | 101533183 |
| 20078310 | 20133933 | 1.5 | 73.4 | Palliative (P) | 2017-02-26 | 2017-03-15 | FCarboSt | 02 | Y | CETUXIMAB + FLUOROURACIL | 100647413 |
| 20078460 | 20133934 | 1.8 | 66.05 | Adjuvant (A) | null | 2019-01-27 | Capecitabine+Cisplatin+Streptozocin | N | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100966912 |
| 20078985 | 20133935 | 1.6 | 66 | 03 | 2018-03-31 | 2018-04-07 | IPILIMUMAB + NIVOLUMAB | 99 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100782911 |
| 20079923 | 20133936 | 1.58 | 72.4 | null | 2018-04-22 | 2018-05-01 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | ECF | 101127750 |